We are live on ! Find out more
LLY icon

Eli Lilly

1,005 hedge funds and large institutions have $42.1B invested in Eli Lilly in 2013 Q4 according to their latest regulatory filings, with 112 funds opening new positions, 341 increasing their positions, 406 reducing their positions, and 69 closing their positions.

New
Increased
Maintained
Reduced
Closed

62% more first-time investments, than exits

New positions opened: 112 | Existing positions closed: 69

11% more call options, than puts

Call options by funds: $460M | Put options by funds: $416M

3% more funds holding

Funds holding: 9741,005 (+31)

2% more capital invested

Capital invested by funds: $41.1B → $42.1B (+$950M)

0.62% more ownership

Funds ownership: 72.69%73.31% (+0.62%)

16% less repeat investments, than reductions

Existing positions increased: 341 | Existing positions reduced: 406

17% less funds holding in top 10

Funds holding in top 10: 2319 (-4)

Holders
1,005
Holders Change
+31
Holders Change %
+3.18%
% of All Funds
29.16%
Holding in Top 10
19
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-17.39%
% of All Funds
0.55%
New
112
Increased
341
Reduced
406
Closed
69
Calls
$460M
Puts
$416M
Net Calls
+$44.3M
Net Calls Change
-$109M
Name Holding Trade Value Shares
Change
Change in
Stake
SAMC
876
Shinko Asset Management Company
Japan
$226K -$18.3K -365 -8%
SIC
877
Salem Investment Counselors
North Carolina
$226K +$2.5K +50 +1%
Fisher Asset Management
878
Fisher Asset Management
Washington
$226K +$222K +4,429 New
WMSA
879
Weiss Multi-Strategy Advisers
New York
$225K -$1.29M -25,740 -85%
HDIM
880
Hanson & Doremus Investment Management
Vermont
$224K
NA
881
NSB Advisors
New York
$224K
WKA
882
Wilson Kemp & Associates
Michigan
$224K +$220K +4,400 New
CL
883
Croft-Leominster
Maryland
$223K
RT
884
Reliance Trust
Georgia
$222K -$32.9K -656 -13%
BSA
885
Braun Stacey Associates
New York
$219K
CCG
886
Chatham Capital Group
Georgia
$219K
WP
887
WMS Partners
Maryland
$216K +$2.55K +51 +1%
ATC
888
Argent Trust Company
Louisiana
$213K -$24.7K -494 -11%
CRC
889
Curi RMB Capital
Illinois
$212K +$208K +4,163 New
TRCT
890
Tower Research Capital (TRC)
New York
$210K -$768K -15,345 -79%
CDH
891
Charles D. Hyman
$209K -$5.01K -100 -2%
NYLIM
892
New York Life Investment Management
New York
$209K
SRC
893
Shufro Rose & Co
New York
$209K +$205K +4,102 New
RHJA
894
Rice Hall James & Associates
California
$207K
EWM
895
Endurance Wealth Management
Rhode Island
$204K
LK
896
Lumbard & Kellner
New Hampshire
$204K +$200K +4,000 New
BOS
897
Bank of Stockton
California
$203K -$10K -200 -5%
AWM
898
Avior Wealth Management
Nebraska
$200K +$196K +3,924 New
AW
899
Alpha Windward
Massachusetts
$196K +$11.3K +226 +6%
AA
900
AlphaMark Advisors
Kentucky
$196K +$62.6K +1,250 +48%

LLY Hedge Fund Activity: Q4 2013 in Review

1,005 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Eli Lilly (LLY) for Q4 2013, worth a combined $42.1B — up 2.3% from $41.1B a quarter earlier.

Buyers outnumbered sellers: 112 funds opened new LLY positions and 69 closed out — a net gain of 43 holders — while 341 added to existing stakes and 406 trimmed.

The largest buyer was Franklin Resources, adding an estimated $711M. The largest seller was Fidelity Investments, cutting an estimated $141M.

  • 1,005 institutional investors held Eli Lilly (LLY) as of Q4 2013, up from 974 in Q3 2013.
  • Funds reported $42.1B of Eli Lilly stock for Q4 2013, up 2.3% quarter-over-quarter.
  • 112 funds opened new Eli Lilly positions in Q4 2013 and 69 closed out, a net change of +43 holders.
  • The largest Eli Lilly buyer in Q4 2013 was Franklin Resources, an estimated $711M added.
  • The largest Eli Lilly seller in Q4 2013 was Fidelity Investments, an estimated $141M sold.

Based on aggregated 13F filings for Q4 2013.